VIR Return on Tangible Equity | Vir Biotechnology, Inc.

Vir Biotechnology, Inc. (VIR) Return on Tangible Equity

2026-06-30: Return Tang Equity -26.10%.
2026-03-31: Return Tang Equity -55.72%.
2025-12-31: Return Tang Equity -58.63%.
2025-09-30: Return Tang Equity -64.26%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-26.10%
2026-03-31	-55.72%
2025-12-31	-58.63%
2025-09-30	-64.26%
2025-06-30	-59.23%
2025-03-31	-56.34%
2024-12-31	-46.12%
2024-09-30	-43.63%
2024-06-30	-34.13%
2024-03-31	-35.28%
2023-12-31	-39.13%
2023-09-30	-36.27%
2023-06-30	-14.63%
2023-03-31	-7.36%
2022-12-31	25.05%
2022-09-30	53.64%
2022-06-30	55.77%
2022-03-31	61.37%
2021-12-31	37.43%
2021-09-30	-11.95%
2021-06-30	-41.45%
2021-03-31	-61.87%
2020-12-31	-42.86%
2020-09-30	-32.47%
2020-06-30	-40.65%
2020-03-31	-62.20%
2019-12-31	-43.39%
2019-09-30	46.12%
2019-06-30	48.23%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-58.63%
2024-12-31	-46.12%
2023-12-31	-39.13%
2022-12-31	25.05%
2021-12-31	37.43%
2020-12-31	-42.86%
2019-12-31	-43.39%
2018-12-31	59.09%
2017-12-31	101.36%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NOVAVAX INC (NVAX)	United States	$1.748B	-6.26
Hemab Therapeutics Holdings, Inc. (COAG)	United States	$1.672B
Vericel Corp (VCEL)	United States	$2.011B	93.97
Immunocore Holdings plc (IMCR)		$1.613B	-90.43
Taysha Gene Therapies, Inc. (TSHA)	United States	$1.564B	-14.80
RECURSION PHARMACEUTICALS, INC. (RXRX)	United States	$2.080B	-3.78
Kodiak Sciences Inc. (KOD)	United States	$2.090B	-10.12
ADMA BIOLOGICS, INC. (ADMA)	United States	$2.131B	11.16
Inhibrx Biosciences, Inc. (INBX)	United States	$1.477B	-10.08
Maze Therapeutics, Inc. (MAZE)	United States	$1.457B	-12.40